Home
Line Iden Berge's picture

Line Iden Berge

Associate Professor
  • E-mailline.berge@uib.no
  • Phone+47 55 58 61 15
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen

I'm a medical doctor, specialist in psychiatry, PhD in epidemiology from 2014 at UiB. My current positions are associate professor in Elderly Medicine, Centre for Elderly and Nursing Home Medicine, and senior doctor at NKS Olaviken gerontopsychiatric hospital.  From 2019-2022  I was a post-doc affiliated with the LIVE@Home.Path Innovating the clinical pathway for home-dwelling people with dementia and their families. A mixed-method randomized controlled trial - Prosjektbanken (forskningsradet.no), which applied a stepped-wedge design to explore if a multicomponent intervention could improve rescource utilization and burden for caregivers to people with dementia residing at home.  Toghether with PhD candidate Marie Hidle Gedde, I investigated the impact of the intervention and the Covid-19 pandemic on behavioral and psychological symptoms of dementia. 

From august 2022 I'm the PI of the DARK.DEM trial Virtual darkness and digital phenotyping in specialized and municipal dementia care: The DARK.DEM randomized controlled trial. - Prosjektbanken (forskningsradet.no), in which we will explore if blue light depleted evening light can alliviate agitation and other behavioral and psychological symptoms of dementia. We will also deveop digital biomarkers for agitation by correlating data from smartwatches with data from traditional psychometric scales. 

I'm a menber of the research board at IGS, rund the research shool in global public health and primary care Forskerskole i samfunnsmedisinske fag | Institutt for global helse og samfunnsmedisin | UiB and is currently the head of Faglig Forum, Alrek Health Care Cluster Faglig forum - Alrek (alrekhelseklynge.no). I'm an associate board memeber of the American Journal of Geriatic Psychiatry. 

I am affiliated with the Master's Programme in Health and Society | University of Bergen (uib.no) I teach in ageing, social inequalities in health and methods, supervise masterstudents and have course responsibility for Den akademiske prosessen: frå idé til presentasjon | Universitetet i Bergen (uib.no) 

Academic article
  • Show author(s) (2023). Access to, use of, and experiences with social alarms in home-living people with dementia: results from the LIVE@Home.Path trial. Frontiers in Aging Neuroscience.
  • Show author(s) (2022). The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial. BMC Medicine.
  • Show author(s) (2022). The acceptability, adoption, and feasibility of a music application developed using participatory design for home-dwelling persons with dementia and their caregivers. The “Alight” app in the LIVE@Home.Path trial. Frontiers in Psychiatry. 1-18.
  • Show author(s) (2022). Impact of COVID-19 restrictions on behavioural and psychological symptoms in home-dwelling people with dementia: A prospective cohort study (PAN.DEM). BMJ Open.
  • Show author(s) (2022). Gender specific early treatment for women with alcohol addiction (EWA): Impact on work related outcomes. A 25-year registry follow-up of a randomized controlled trial (RCT). Drug and Alcohol Dependence. 8 pages.
  • Show author(s) (2022). Factors associated with formal and informal resource utilization in nursing home patients with and without dementia: cross-sectional analyses from the COSMOS trial. BMC Health Services Research. 1-10.
  • Show author(s) (2021). Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD). Health Economics Review. 15 pages.
  • Show author(s) (2021). The consequences of COVID-19 lockdown for formal and informal resource utilization among home-dwelling people with dementia: results from the prospective PAN.DEM study. BMC Health Services Research. 1-12.
  • Show author(s) (2021). How, Why and Where it Hurts—Breaking Down Pain Syndrome Among Nursing Home Patients With Dementia: A Cross-Sectional Analysis of the COSMOS Trial. Pain Management Nursing. 319-326.
  • Show author(s) (2021). Genetic Dominant Variants in STUB1, Segregating in Families with SCA48, Display In Vitro Functional Impairments Indistinctive from Recessive Variants Associated with SCAR16. International Journal of Molecular Sciences.
  • Show author(s) (2021). Factors associated with access to assistive technology and telecare in home-dwelling people with dementia: baseline data from the LIVE@Home.Path trial. BMC Medical Informatics and Decision Making. 1-14.
  • Show author(s) (2021). Age and emotional distress during covid-19: Findings from two waves of the norwegian citizen panel. International Journal of Environmental Research and Public Health (IJERPH). 14 pages.
  • Show author(s) (2021). Access to and interest in assistive technology for home-dwelling people with dementia during the COVID-19 pandemic (PAN.DEM). International Review of Psychiatry. 9 pages.
  • Show author(s) (2020). The negative impact of psychotropic drug use on quality of life in nursing home patients at different stages of dementia: Cross-sectional analyses from the COSMOS trial. Journal of the American Medical Directors Association. 1623-1628.
  • Show author(s) (2020). Less is more: The impact of deprescribing psychotropic drugs on behavioral and psychological symptoms and daily functioning in nursing home patients. Results from the Cluster-Randomized Controlled COSMOS Trial. The American journal of geriatric psychiatry. 304-315.
  • Show author(s) (2020). LIVE@Home.Path--innovating the clinical pathway for home-dwelling people with dementia and their caregivers: Study protocol for a mixed-method, stepped-wedge, randomized controlled trial. Trials. 1-16.
  • Show author(s) (2018). Diabetes is associated with decreased migraine risk: A nationwide cohort study. Cephalalgia. 1759-1764.
  • Show author(s) (2016). Health anxiety and risk of ischaemic heart disease: A prospective cohort study linking the Hordaland Health Study (HUSK) with the Cardiovascular Diseases in Norway (CVDNOR) project. BMJ Open. 9 pages.
  • Show author(s) (2015). The prospective association between health anxiety and cancer detection: A cohort study linking the Hordaland Health Study (HUSK) with the Norwegian Cancer Registry. Journal of Psychosomatic Research. 148-152.
  • Show author(s) (2015). Depression in persons with diabetes by age and antidiabetic treatment: A crosssectional analysis with data from the hordaland health study. PLOS ONE. 15 pages.
  • Show author(s) (2015). Attempts to improve and confidence in improving health behaviour in 40-49 year olds with and without coronary heart disease: The Hordaland Health Study. European Journal of Cardiovascular Nursing. e60-e69.
  • Show author(s) (2014). Is depression a risk factor for diabetic foot ulcers? 11-years follow-up of the Nord-Trøndelag Health Study (HUNT). Journal of Diabetes and its Complications (JDC). 20-25.
  • Show author(s) (2013). Prevalence and characteristics of depressive disorders in type 1 diabetes. BMC Research Notes.
  • Show author(s) (2013). Does diabetes have a protective effect on migraine? Epidemiology. 129-134.
  • Show author(s) (2013). Co-morbidity between diabetes, migraine and depression. Norsk Epidemiologi. 83-87.
  • Show author(s) (2012). Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents. Diabetic Medicine. 509-514.
Lecture
  • Show author(s) (2023). Helsetjenester til personer med demens.
Popular scientific lecture
  • Show author(s) (2023). Forskernatt, søvnens makt: ungdom, overgang, alderdom. .
  • Show author(s) (2023). Forskernatt «Søvnens makt: Ungdom – overgang – alderdom».
Academic lecture
  • Show author(s) (2023). Virtual darkness and digital phenotyping in specialized and municipal dementia care. The DARK.DEM trial.
  • Show author(s) (2023). The effectiveness of a multicomponent intervention on caregiver burden and informal care time in home-dwelling people with dementia and their caregivers. Results from the stepped wedge randomized controlled LIVE@Home.Path trial.
  • Show author(s) (2023). Kronoterapi mot adferdsforstyrrelser ved demens.
  • Show author(s) (2023). Chronotheraphy for behavioral and psychological symptoms of dementia.
  • Show author(s) (2022). Konsekvenser av covid-19 restriksjonene for eldre og personer med demens.
  • Show author(s) (2022). Cost-effectiveness of LIVE@Home.Path care model for home-dwelling persons with dementia: preliminary results from a stepped-wedge randomized controlled trial.
  • Show author(s) (2022). Brighter Age: Alderspsykiatri i nytt lys.
Non-fiction book
  • Show author(s) (2016). Hva gikk galt hos legen? Når dialogen svikter. Spartacus.
Feature article
  • Show author(s) (2022). Psykose og depresjon hos eldre under koronapandemien. Forskning.no.
  • Show author(s) (2021). Eldre har også lidd under pandemien. Bergens Tidende.
  • Show author(s) (2020). Politikerne hykler om velferdsteknologi. Vårt land.
  • Show author(s) (2020). Politikerne hykler om velferdsteknologi. Vårt land.
Letter to the editor
  • Show author(s) (2020). Intensive Medicine and Nursing Home Care in Times of SARS CoV-2: A Norwegian Perspective. The American journal of geriatric psychiatry. 792-793.
Doctoral dissertation
  • Show author(s) (2014). Depression and migraine comorbid to diabetes.
Programme management
  • Show author(s) (2024). Søvn gjennom livsløpet: Kan søvnproblemer øke risikoen for demens? Med overlege og førsteamanuensis Line Iden Berge.
Poster
  • Show author(s) (2023). Light exposure, sleep quality, and sleepiness as predictors of memory decline in older adults: A cohort study from Norway .
  • Show author(s) (2021). Multicomponent intervention with medication reviews impact on psychotropic drug use and behavioural and psychological symptoms in home-dwelling persons with dementia. .
  • Show author(s) (2021). LIVE@Home.Path: Innovating the clinical pathway for home-dwelling people with dementia and caregivers .
  • Show author(s) (2021). Impact of medication review on psychotropic drug use for behavioral and psychological symptoms of home-dwelling persons with dementia. .
  • Show author(s) (2020). Access to and interest in assistive technology for home-dwelling people with dementia under COVID-19.
  • Show author(s) (2019). LIVE@Home.Path.
  • Show author(s) (2019). Ethics, privacy and regulations in research including home-dwelling people with dementia. .
  • Show author(s) (2019). Digital Assessments for Individualized Dementia Care.
  • Show author(s) (2019). Alight: The development and pilot testing of a prototype tablet application for elderly persons with affective disorders or cognitive impairment. A collaboration between patients and caregivers, clinical, academic and commercial organizations .
Errata
  • Show author(s) (2020). Corrigendum: Sensing Technology to Monitor Behavioral and Psychological Symptoms and to Assess Treatment Response in People With Dementia. A Systematic Review (Frontiers in Pharmacology, (2020), 10, (1699), 10.3389/fphar.2019.01699). Frontiers in Pharmacology.
Academic literature review
  • Show author(s) (2020). Sensing technology to monitor behavioral and psychological symptoms and to assess treatment response in people with dementia: A systematic review. Frontiers in Pharmacology. 1-13.
  • Show author(s) (2015). Comorbidity between type 2 diabetes and depression in the adult population: directions of the association and its possible pathophysiological mechanisms. International Journal of Endocrinology. 7 pages.

More information in national current research information system (CRIStin)